Results 31 to 40 of about 1,396,067 (212)

Expression and Functions of the CB2 Receptor in Human Leukocytes

open access: yesFrontiers in Pharmacology, 2022
The cannabinoid CB2 receptor was cloned from the promyeloid cell line HL-60 and is notably expressed in most, if not all leukocyte types. This relatively restricted localization, combined to the absence of psychotropic effects following its activation ...
Mélissa Simard   +10 more
doaj   +1 more source

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity

open access: yesNature Communications, 2017
The cannabinoid CB2 receptor (CB2R) represents a promising therapeutic target for various forms of tissue injury and inflammatory diseases. Although numerous compounds have been developed and widely used to target CB2R, their selectivity, molecular mode ...
Marjolein Soethoudt   +31 more
semanticscholar   +1 more source

The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system [PDF]

open access: yes, 2008
INTRODUCTION: Ghrelin and cannabinoids stimulate appetite, this effect possibly being mediated by the activation of hypothalamic AMP-activated protein kinase (AMPK), a key enzyme in appetite and metabolism regulation. The cannabinoid receptor type 1 (CB1)
Judith Harvey-White   +59 more
core   +3 more sources

Progress in Brain Cannabinoid CB2 Receptor Research: From Genes to Behavior

open access: yesNeuroscience and Biobehavioral Reviews, 2019
HighlightsCannabinoid CB2R was initially assumed to be exclusively in the periphery.Technological innovations have revealed functional CB2R expression in neurons.Species differences exist in CB2R genes, receptor expression, and function.Region‐specific ...
C. Jordan, Zheng-Xiong Xi
semanticscholar   +1 more source

Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia

open access: yesFrontiers in Veterinary Science, 2019
Growing evidence indicates cannabinoid receptors as potential therapeutic targets for chronic pain. Consequently, there is an increasing interest in developing cannabinoid receptor agonists for treating human and veterinary pain. To better understand the
Roberto Chiocchetti   +9 more
doaj   +1 more source

Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells [PDF]

open access: yesPeerJ, 2019
Background Synthetic cannabinoids are a commonly used class of recreational drugs that can have significant adverse effects. There have been sporadic reports of co-consumption of illicit drugs with rodenticides such as warfarin and brodifacoum (BFC) over
Shivani Sachdev   +4 more
doaj   +2 more sources

Expression of the endocannabinoid receptors in human fascial tissue

open access: yesEuropean Journal of Histochemistry, 2016
Cannabinoid receptors have been localized in the central and peripheral nervous system as well as on cells of the immune system, but recent studies on animal tissue gave evidence for the presence of cannabinoid receptors in different types of tissues ...
C. Fede   +6 more
doaj   +1 more source

Cannabinoid receptor 2 signal promotes type 2 immunity in the lung

open access: yesCell Insight, 2023
Type 2 immunity in the lung protects against pathogenic infection and facilitates tissue repair, but its dysregulation may lead to severe human diseases. Notably, cannabis usage for medical or recreational purposes has increased globally.
Tingting Liu   +6 more
doaj   +1 more source

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma

open access: yesBMC Cancer, 2018
Background The anti-tumor properties of cannabinoids have been investigated in many in vitro and in vivo studies. Many of these anti-tumor effects are mediated via cannabinoid receptor types 1 and 2 (CB1 and CB2), comprising the endocannabinoid system ...
Mohammed I. Khan   +7 more
doaj   +1 more source

The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

open access: yesBritish Journal of Pharmacology, 2016
Here, we have characterized 3‐cyclopropyl‐1‐(4‐(6‐((1,1‐dioxidothiomorpholino)methyl)‐5‐fluoropyridin‐2‐yl)benzyl)imidazolidine‐2,4‐dione hydrochloride (LEI‐101) as a novel, peripherally restricted cannabinoid CB2 receptor agonist, using both in vitro ...
P. Mukhopadhyay   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy